The promise of fully-integrated PET/MR imaging: Non-invasive clinical quantification of cerebral glucose metabolism.
A fully-automated processing pipeline is presented to support non-invasive absolute quantification of cerebral metabolic rate of glucose (CMRGlc) in a clinical setting. Our method takes full advantage of 'anato-metabolic' information associated with fully-integrated PET/MR imaging. Methods: Ten healthy volunteers (27 ± 7 years, 70 ± 10 kg, 5M/5F) underwent a test-retest [18F]FDG PET/MRI examination of the brain. The imaging protocol consisted of a 60-min PET list-mode acquisition, with parallel MR-acquisitions, including 3D time-of-flight MR-angiography (TOF-MRA), MR-navigators (Nav) and a T1-w MR scan. State-of-art MR-based attenuation correction (MR-AC) map (pseudo-CT, pCT) was derived from T1-w MRI. To validate MR-AC in the context of IDIF derivation, a low-dose CT scan was also performed. Arterial blood samples (AIF) were collected as the reference standard. The developed pipeline allows the derivation of an IDIF, which is subsequently used to create CMRGlc maps by performing Patlak analysis. The pipeline also includes motion correction (MC) using the Nav-sequence as well as a novel partial volume correction (PVC) method that accounts for background heterogeneity. Finally, CMRGlc maps are incorporated for generating a normative database to allow detection of abnormalities in future patient scans. To assess the performance of the developed pipeline, IDIFs derived using both CT-AC (CT-IDIF) and MR-AC (pCT-IDIF) were compared against the reference standard of AIF using the absolute percentage difference between the area-under-the-curves (AUCs) as well as differences in regional CMRGlc values. Results: The absolute percentage difference between AUCs obtained from the AIF and the IDIFs was determined as (1.4 ± 1.0) % and (3.4 ± 2.6) % for CT-IDIF and pCT-IDIF, respectively. Regional CMRGlc calculated based on these input functions showed an excellent correlation with those determined using AIF, with a value of R2 = 0.98 for CMRGlc values derived based on the IDIF-CT and a value of R2 = 0.96 for those determined using the IDIF-pCT. Conclusion: Taking advantage of the capabilities of fully-integrated PET/MR imaging, we have established an automated, clinically feasible computational pipeline that provides absolute values of regional CMRGlc non-invasively. We envision that our methodology might significantly contribute to the goal of personalized imaging in the clinical arena.